TY - GEN AU - Roche, Victoria F. AU - Zito, S. William AU - Lemke, Thomas L. AU - Williams, David A., TI - Foye's principles of medicinal chemistry SN - 9781496385024 U1 - 615.19 PY - 2020/// CY - Philadelphia : PB - Wolters Kluwer , KW - Química farmacéutica KW - Farmacología KW - Química KW - Farmacia (Ciencia) KW - Química y farmacia N1 - Incluye índice.; Incluye referencias bibliográficas al final de cada capítulo. ; PART I: PRINCIPLES; Chapter 1. Introduction to Medicinal Chemistry.-; Chapter 2. Fundational Principles and Functional Goup Impavt on Activity.-; Chapter 3. Drug Metabolism.-; Chapter 4. Membrane Drug Transporters.-; Chapter 5. Principles of Biotechnology-Derived Drugs; PART II: RECEPTOR TARGETS; Chapter 6. G. Protein-Coupled Receptors.-; Chapter 7. Nuclear Receptors.-; Chapter 8. Ion Channel Receptors.-; Chapter 9. Enzyme/Catalytic Receptors; PART III: PHARMACODYNAMIC AGENTS; Section I: Drugs impacting the central nervous system; Chapter 10. Drugs Used to Treat Neuromuscular Disorders.-; Chapter 11. Drugs Used to Treat Mental, Bahavioral, and Cognitive Disorders.-; Chapter 12. Drugs Used to Induce/Support Sedation or Anesthesia.-; Chapter 13. Drugs Used to Treat Seizure Disorders; Section 2: Drugs impacting pain perception; Chapter 14. Drugs Used to Treat Pain: Centrally Acting Agents.-; Chapter 15. Drugs Used to Treat Pain: Peripherally Acting Agents; Section 3: Drugs impacting the cardiovascular system; Chapter 16. Drugs Used to Treat Cardiac Disorders.-; Chapter 17. Drugs Used to Treat Hupertensive/Hipotensive Disorders.-; Chapter 18. Drugs Used to Treat Coagulation Disorders.-; Chapter 19. Drugs Used to Treat Dyslipidemic Disorders; Section 4: Drugs impacting hormonal systems; Chapter 20. Drugs Used to Treat Diabetic Disorders.-; Chapter 21. Drugs Used to Treat Inflammatory and Corticosteroid Deficiency Disorders.-; Chapter 22. Drugs Used to Treat Thyroid Disorders.-; Chapter 23. Drugs Used to Treat Calcium-Dependent Disorders.-; Chapter 24. Drugs Used to Advance Men's and Women's Health; Section 5: Drugs impacting immune, gastrointestinal and genitourinary systems; Chapter 25. Drugs Used to Treat Allergic Disorders.-; Chapter 26. Drugs Used to Treat Gastrointestinal and Genitourinary Disorders; Section 6: Drugs impacting ocular, nasal and pulmonary systems; Chapter 27. Drugs Used to Treat Ocular and Nasal Congestion Disorders.-; Chapter 28. Drugs Used to Treat Pulmonary Disorders; Section 7: Drugs impacting infectious and neoplastic disease processes /; Chapter 29. Drugs Used to Treat Bacterial Infections.-; Chapter 30. Drugs Used to Treat Viral Infections.-; Chapter 31. Drugs Used to Treat Fungal Infections.-; Chapter 32. Drugs Used to Treat Parasitic Infections.-; Chapter 33. Drugs Used to Treat Neoplastic Diseases; Section 8: Therapeutic biologics /; Chapter 34. Biologic Used in the Treatment of Disease; PART IV: DISEASE STATE MANAGEMENT; Chapter 35. Coronary Artery Disease.-; Chapter 36. Rheumatoid Arthritis.-; Chapter 37. Nutrition and Obesity.- ER -